{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:00:33Z","timestamp":1773154833247,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["FIS PI10\/2635"],"award-info":[{"award-number":["FIS PI10\/2635"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PI11\/02512"],"award-info":[{"award-number":["PI11\/02512"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PI11\/00376"],"award-info":[{"award-number":["PI11\/00376"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PI13\/0796"],"award-info":[{"award-number":["PI13\/0796"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PI14\/0700"],"award-info":[{"award-number":["PI14\/0700"]}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y Prevenci\u00f3n del SIDA en Espa\u00f1a","doi-asserted-by":"crossref","award":["FIPSE 36610"],"award-info":[{"award-number":["FIPSE 36610"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y Prevenci\u00f3n del SIDA en Espa\u00f1a","doi-asserted-by":"crossref","award":["36572\/06"],"award-info":[{"award-number":["36572\/06"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministerio de Sanidad, Politica Social e Igualdad","award":["EC11-293"],"award-info":[{"award-number":["EC11-293"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["2009 SGR 1061"],"award-info":[{"award-number":["2009 SGR 1061"]}]},{"name":"Red de Investigaci\u00f3n en SIDA","award":["RIS RD06\/006\/0022"],"award-info":[{"award-number":["RIS RD06\/006\/0022"]}]},{"name":"Red de Investigaci\u00f3n en SIDA","award":["RD06\/0006\/1004"],"award-info":[{"award-number":["RD06\/0006\/1004"]}]},{"name":"Red de Investigaci\u00f3n en SIDA","award":["RD012\/0017\/0014"],"award-info":[{"award-number":["RD012\/0017\/0014"]}]},{"name":"Red de Investigaci\u00f3n en SIDA","award":["RD12\/0017\/0005"],"award-info":[{"award-number":["RD12\/0017\/0005"]}]},{"name":"I Convocatoria de Proyectos de Investigaci\u00f3n en VIH y Hepatitis 2013","award":["GLD 1300168"],"award-info":[{"award-number":["GLD 1300168"]}]},{"name":"Programa de Intensificaci\u00f3n de Investigadores, Instituto de Salud Carlos III","award":["INT12\/383"],"award-info":[{"award-number":["INT12\/383"]}]},{"name":"Programa de Intensificaci\u00f3n de Investigadores, Instituto de Salud Carlos III","award":["INT13\/232"],"award-info":[{"award-number":["INT13\/232"]}]},{"name":"Programa de Intensificaci\u00f3n de Investigadores, Instituto de Salud Carlos III","award":["INT11\/240"],"award-info":[{"award-number":["INT11\/240"]}]}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clnu.2017.05.032","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T02:00:17Z","timestamp":1496973617000},"page":"1340-1347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"37","author":[{"given":"Pere","family":"Domingo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Miguel","family":"Gallego-Escuredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma del Mar","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Gracia","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan Carles","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2017.05.032_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2011.06.003","article-title":"Cardiovascular implications of HIV-induced dyslipidemia","volume":"219","author":"Giannarelli","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2017.05.032_bib2","first-page":"112","article-title":"Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy: systematic review of current knowledge","volume":"14","author":"Domingo","year":"2012","journal-title":"AIDS Rev"},{"key":"10.1016\/j.clnu.2017.05.032_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00001432-200302000-00004","article-title":"Lipid profiles associated with antiretroviral drug choices","volume":"16","author":"van der Valk","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clnu.2017.05.032_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.clnu.2017.05.032_bib5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yrtph.2003.07.002","article-title":"Health benefits and potential risks related to consumption of fish or fish oil","volume":"38","author":"Sidhu","year":"2003","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.clnu.2017.05.032_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/QAI.0b013e31802c2f3d","article-title":"Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy. A randomized prospective study","volume":"44","author":"De Truchis","year":"2007","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clnu.2017.05.032_bib7","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/497273","article-title":"Randomized study of the safety and efficacy of fish oil (Omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia","volume":"41","author":"Wohl","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clnu.2017.05.032_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/ajcn\/71.5.1085","article-title":"Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men","volume":"71","author":"Mori","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2017.05.032_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.HYP.34.2.253","article-title":"Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans","volume":"34","author":"Mori","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.clnu.2017.05.032_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/ajcn\/68.1.52","article-title":"Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans","volume":"68","author":"Grimsgaard","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2017.05.032_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.CIR.102.11.1264","article-title":"Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men","volume":"102","author":"Mori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2017.05.032_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biochi.2010.05.005","article-title":"Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) \u2013 implications for dietary recommendations","volume":"93","author":"Guesnet","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.clnu.2017.05.032_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/phrs.1999.0495","article-title":"Health benefits of docosahexanoic acid (DHA)","volume":"40","author":"Horrocks","year":"1999","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clnu.2017.05.032_bib14","doi-asserted-by":"crossref","first-page":"e13896","DOI":"10.1371\/journal.pone.0013896","article-title":"Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1\/ART-associated lipodystrophy syndrome","volume":"5","author":"Domingo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2017.05.032_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dub\u00e9","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"RR-17","key":"10.1016\/j.clnu.2017.05.032_bib16","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance for case definition for AIDS among adolescents and adults","volume":"41","author":"Centers for Disease Control","year":"1993","journal-title":"MMWR"},{"key":"10.1016\/j.clnu.2017.05.032_bib17","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","article-title":"Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease","volume":"106","author":"Kris-Etherton","year":"2002","journal-title":"Circulation"},{"issue":"25 Pt B","key":"10.1016\/j.clnu.2017.05.032_bib18","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2017.05.032_bib19","unstructured":"Division of AIDS table for grading the severity of adult and pediatric adverse events version 1.0, December, 2004; clarification August 2009. Available at: http:\/\/rcc.tech-res-intl.com\/tox_tables.htm. [accessed 12.05.14.]."},{"key":"10.1016\/j.clnu.2017.05.032_bib20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/651117","article-title":"Relationship between HIV\/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens","volume":"50","author":"Domingo","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clnu.2017.05.032_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-2275(20)38861-1","article-title":"Direct transesterification of all classes of lipids in a one-step reaction","volume":"27","author":"Lepage","year":"1986","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.clnu.2017.05.032_bib22","doi-asserted-by":"crossref","first-page":"e89088","DOI":"10.1371\/journal.pone.0089088","article-title":"Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV\/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study","volume":"9","author":"Domingo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2017.05.032_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1089\/aid.2014.0005","article-title":"Effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia","volume":"30","author":"Paranandi","year":"2014","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.clnu.2017.05.032_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/hiv.12046","article-title":"Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients","volume":"14","author":"Metkus","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.clnu.2017.05.032_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/00365540903168056","article-title":"Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study","volume":"41","author":"Thusgaard","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clnu.2017.05.032_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAI.0b013e31815bace2","article-title":"Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186","volume":"47","author":"Gerber","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clnu.2017.05.032_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1071\/SH06001","article-title":"A\u00a0randomised controlled trial of omega-3 fatty acid supplementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy","volume":"3","author":"Carter","year":"2006","journal-title":"Sex Health"},{"key":"10.1016\/j.clnu.2017.05.032_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-2275(20)39881-3","article-title":"Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages","volume":"36","author":"Suzukawa","year":"1995","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.clnu.2017.05.032_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0021-9150(98)00301-3","article-title":"Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins","volume":"143","author":"Pownall","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2017.05.032_bib30","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/diabetes.51.8.2377","article-title":"Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia","volume":"51","author":"Chan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2017.05.032_bib31","first-page":"1059","article-title":"Olive and sesame oil effect on lipid profile of hypercholesterolemic patients, which better?","volume":"4","author":"Namayendeh","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.clnu.2017.05.032_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.nut.2014.12.016","article-title":"Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome","volume":"31","author":"Venturini","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2017.05.032_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1993.tb35714.x","article-title":"Dietary marine fish oils and insulin action in type 2 diabetes","volume":"683","author":"Kasim","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clnu.2017.05.032_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.7326\/0003-4819-123-12-199512150-00003","article-title":"Effects of n23 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized control trial","volume":"123","author":"Toft","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2017.05.032_bib35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/diacare.20.6.913","article-title":"The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM","volume":"20","author":"Dunstan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2017.05.032_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1017\/S0029665113001031","article-title":"n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions","volume":"72","author":"Calder","year":"2013","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clnu.2017.05.032_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041433-200204000-00007","article-title":"Dietary polyunsaturated fatty acids and regulation of gene transcription","volume":"13","author":"Jump","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.clnu.2017.05.032_bib38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/aid.2011.0088","article-title":"Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial","volume":"28","author":"Hileman","year":"2012","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.clnu.2017.05.032_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clnu.2017.05.032_bib40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.ijo.0803698","article-title":"Lipodystrophy in HIV 1-infected patients: lessons for obesity research","volume":"31","author":"Villarroya","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.clnu.2017.05.032_bib41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/oby.2002.70","article-title":"Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor \u03b3","volume":"10","author":"Chambrier","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.clnu.2017.05.032_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1258\/ijsa.2009.009324","article-title":"Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates","volume":"21","author":"Manfredi","year":"2010","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.clnu.2017.05.032_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/01.ATV.0000057393.97337.AE","article-title":"Omega-3 fatty acids and cardiovascular disease. New recommendations from the American Heart Association","volume":"23","author":"Kris-Etherton","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561417302145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561417302145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:14:08Z","timestamp":1659093248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561417302145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0261561417302145"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2017.05.032","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2017.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}